Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (246)
- Medicines safety (146)
- COVID-19 (144)
- Prescription medicines (129)
- Regulatory compliance (120)
- COVID-19 vaccines (88)
- Legislation (78)
- Therapeutic goods regulation (71)
- Listed medicines (48)
- Non-prescription medicines (43)
- Medical devices safety (42)
- Safety (40)
- Vaping hub (33)
- Complementary medicines (30)
- Manufacturing (28)
- Labelling and packaging (25)
- Assessed listed medicines (24)
- Scheduling (national classification system) (23)
- Over the counter (OTC) medicines (21)
- Compliance and enforcement hub (20)
- Medicinal cannabis hub (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (17)
- Alert/Advisory (12)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Registered complementary medicines (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1055 result(s) found, displaying 526 to 550
-
Media releasesOn 27 September 2021 the TGA granted provisional determination to Roche Products Pty Ltd in relation to the COVID-19 treatment tocilizumab (ACTEMRA).
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to Tianda Pharmaceuticals Australia Pty Ltd for alleged unlawful advertising of a listed medicine in relation to COVID-19.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
-
Media releasesLawyers for the TGA have written to United Australia Party leader, Mr Craig Kelly MP, alleging it has breached copyright and demanding that it stop distributing incomplete extracts of adverse event reports relating to COVID-19 vaccines which the TGA believes could be seriously misleading.
-
Media releasesTGA has placed new restrictions on the prescribing of oral ivermectin
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
-
Media releasesThe TGA has granted provisional approval to Moderna Australia Pty Ltd in relation to the COVID-19 vaccine, Spikevax (elasomeran), for individuals aged 12 years and over.
-
BlogFrom 1 October 2021 you will no longer be able to legally buy nicotine vaping products, such as nicotine e-cigarettes, nicotine pods and liquid nicotine, from overseas websites without first getting a prescription.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Compliance undertakingsEnforceable Undertaking given by Shen Neng Herbal Medicines Group Pty Ltd to the Department of Health
-
-
Media releasesJoint statement from the TGA, Ahpra, Office of the Health Ombudsman and the Health Care Complaints Commission
-
Media releasesThe TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
NoticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesConducting domestic inspections during the Coronavirus (COVID-19) pandemic
-
Media releasesIvermectin is a prescription medicine that is not approved in Australia (or in other OECD countries) to prevent or treat COVID-19 disease, and should not be imported for this indication.
-
Media releasesOn 20 August 2021 the TGA granted provisional determination to Celltrion Healthcare Australia Pty Ltd in relation to regdanvimab.
-
Media releasesOn 20 August 2021 the TGA granted provisional determination to Roche Products Pty Ltd in relation to the combination therapy casirivimab + imdevimab (RONAPREVE)
-
Media releasesOn 20 August 2021 the TGA granted provisional approval to GlaxoSmithKline Australia Pty Ltd in relation to sotrovimab (XEVUDY).